Pinaverium bromide
- A03AX04 (WHO)
- 4-[(2-Bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethyl-4-bicyclo[3.1.1]heptanyl)ethoxy]ethyl]morpholin-4-ium bromide
- 53251-94-8 Y
- 40703
- DBSALT001130 Y
- 37181 N
- 7SCF54H12J
- DTXSID90860655
- Interactive image
- CC1(C2CCC(C1C2)CCOCC[N+]3(CCOCC3)Cc4cc(c(cc4Br)OC)OC)C.[Br-]
- InChI=1S/C26H41BrNO4.BrH/c1-26(2)21-6-5-19(22(26)16-21)7-11-31-12-8-28(9-13-32-14-10-28)18-20-15-24(29-3)25(30-4)17-23(20)27;/h15,17,19,21-22H,5-14,16,18H2,1-4H3;1H/q+1;/p-1 N
- Key:IKGXLCMLVINENI-UHFFFAOYSA-M N
Pinaverium bromide (INN) is a medication used for functional gastrointestinal disorders. It belongs to a drug group called antispasmodics and acts as a calcium channel blocker in helping to restore the normal contraction process of the bowel. It is most effective when taken for a full course of treatment and is not designed for immediate symptom relief or sporadic, intermittent use.[1]
Pinaverium bromide was first registered in 1975 by Solvay Pharmaceuticals (now a division of Abbott Laboratories), and marketed globally using the brand names Dicetel and Eldicet. Generic pinaverium is available in South Korea under a trade name of Disten[2] and in Argentina as Nulite.[3]
Indications
It is indicated for the treatment and relief of symptoms associated with irritable bowel syndrome (IBS) including abdominal pain, bowel disturbances and intestinal discomfort; and treatment of symptoms related to functional disorders of biliary tract.[4]
References
- ^ "Trimebutine Maleate and Pinaverium Bromide for Irritable Bowel Syndrome: A Review of the Clinical Effectiveness, Safety and Guidelines [Internet].". CADTH Rapid Response Reports. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health. November 2015. PMID 26985535.
- ^ "Drug/Drug Information: Disten Tablet". KMLE (in Korean).
- ^ "NULITE". Laboratorio Dominguez.
- ^ Abbott Laboratories (Feb 2012). Dicetel Product Insert/Information Malaysia.
- v
- t
- e
functional
bowel
disorders
Antimuscarinics |
| ||||
---|---|---|---|---|---|
Phosphodiesterase inhibitors | |||||
Acting on serotonin receptors |
| ||||
Other |
and derivatives
(antimuscarinics)
- Tertiary amines: Atropine
- Hyoscyamine
- Quaternary ammonium compounds:
- Methylatropine
- Fentonium bromide
- Cimetropium bromide